Peer-reviewedPublisher termsRSC Medicinal Chemistry
Structure-based virtual screening identifies naturally derived histidine kinase VbrK inhibitors as potential countermeasures against β-lactam antimicrobial resistance
- 1Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University Shenyang 110016 China
Related
- Tryptoline stereoprobe elaboration identifies inhibitors of the GRPEL1–HSPA9 complex
- Heteroaryl-Substituted Secondary Amines as Multifunctional Antimicrobial, Antibiofilm, Acetylcholinesterase, and α-Glucosidase Inhibitors
- Design and Benchmarking of CK2α′-Preferring Inhibitors for Huntington’s Disease: The Limits of Structure-Based Isoform Selectivity
- Integrated machine learning, pharmacophore screening, and structure-based computational approaches for the identification of novel JAK3 inhibitors
- Rigorous Absolute Binding Free Energy Calculations Elucidate Mutation–Driven Resistance Mechanisms of Non–Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors
BibTeX
@article{yan2026structurebased,
title = {{Structure-based virtual screening identifies naturally derived histidine kinase VbrK inhibitors as potential countermeasures against β-lactam antimicrobial resistance}},
author = {Chao Yan and Xiaoyi Li and Jiayin Wang and Bo Jin and Linxiang Zhao and Jiachen Wen},
journal = {RSC Medicinal Chemistry},
year = {2026},
month = oct,
doi = {10.1039/d6md00615a},
url = {https://doi.org/10.1039/d6md00615a},
}
RIS
TY - JOUR
TI - Structure-based virtual screening identifies naturally derived histidine kinase VbrK inhibitors as potential countermeasures against β-lactam antimicrobial resistance
AU - Chao Yan
AU - Xiaoyi Li
AU - Jiayin Wang
AU - Bo Jin
AU - Linxiang Zhao
AU - Jiachen Wen
PY - 2026
DA - 2026/10/12
JO - RSC Medicinal Chemistry
DO - 10.1039/d6md00615a
UR - https://doi.org/10.1039/d6md00615a
SN - 2632-8682
ER -